Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News SCYNEXIS Inc SCYX

Healthcare
SCYNEXIS, Inc. is a biotechnology company. It is pioneering medicine to overcome and prevent difficult-to-treat and drug-resistant infections. It develops antifungal platform fungerps, a novel class of antifungal agents called triterpenoids, that are structurally distinct glucan synthase inhibitors and have generally shown in vitro and in vivo activity against a range of human fungal pathogens,... see more

Recent & Breaking News (NDAQ:SCYX)

MONDAY DEADLINE REMINDER: The Schall Law Firm Encourages Investors in SCYNEXIS, Inc. with Losses of $100,000 to Contact the Firm

Newsfile January 3, 2024

Upcoming SCYX Deadline: Bronstein, Gewirtz & Grossman LLC Reminds Scynexis, Inc. Investors with Substantial Losses to Actively Participate in the Class Action Lawsuit!

Accesswire January 3, 2024

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in SCYNEXIS, Inc. with Losses of $100,000 to Contact the Firm

Accesswire January 3, 2024

SCYX DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important January 8 Deadline in Securities Class Action - SCYX

Newsfile January 2, 2024

Scynexis Ongoing Deadline Alert

Newsfile January 2, 2024

SCYX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Scynexis, Inc. Investors with Substantial Losses to Actively Participate in the Class Action Lawsuit!

Accesswire January 2, 2024

MONDAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in SCYNEXIS, Inc. with Losses of $100,000 to Contact the Firm

Newsfile January 2, 2024

SHAREHOLDER ACTION DEADLINE: The Schall Law Firm Encourages Investors in SCYNEXIS, Inc. with Losses to Contact the Firm

Accesswire January 1, 2024

SCYX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Scynexis, Inc. Investors with Substantial Losses to Actively Participate in the Class Action Lawsuit!

Accesswire January 1, 2024

Scynexis Deadline Alert

Newsfile January 1, 2024

SCYX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Scynexis, Inc. Investors with Substantial Losses to Actively Participate in the Class Action Lawsuit!

Accesswire December 31, 2023

Scynexis Deadline Reminder

Newsfile December 31, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of SCYNEXIS, Inc. (SCYX) Investigation

Accesswire December 31, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of SCYNEXIS, Inc. - SCYX

Newsfile December 30, 2023

SCYX DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important January 8 Deadline in Securities Class Action - SCYX

Newsfile December 30, 2023

SCYX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Scynexis, Inc. Investors with Substantial Losses to Actively Participate in the Class Action Lawsuit!

Accesswire December 29, 2023

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in SCYNEXIS, Inc. with Losses of $100,000 to Contact the Firm

Newsfile December 29, 2023

Scynexis Shareholder Action Reminder

Newsfile December 29, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of SCYNEXIS, Inc. (SCYX) Investigation

Accesswire December 29, 2023

FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in SCYNEXIS, Inc. with to Contact the Firm

Accesswire December 29, 2023